BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
FRANKLIN LAKES, N.J., Jan. 12, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX) issued the following statement in response to receiving a warning letter from the U.S. Food and Drug Administration for its Preanalytical Systems business unit. Richard Byrd, worldwide president of BD Preanalytical Systems said: “Ensuring the safety and quality of our products... Read more